Member access

4-Traders Homepage  >  Shares  >  Amex  >  IGI LABORIGI       

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
IGI Laboratories, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's... 
Sector
Pharmaceuticals
Calendar
03/17Earnings Release
Surperformance© rating of IGI LABORIGI
Trading Rating : Investor Rating : -
More about the company
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 31,9 M
EBIT 2014 3,07 M
Net income 2014 2,85 M
Debt 2014 -
Yield 2014 -
Sales 2015 60,6 M
EBIT 2015 16,3 M
Net income 2015 15,6 M
Debt 2015 -
Yield 2015 -
PER 2014 173,02
PER 2015 33,83
Capi. / Sales 2014 16,2x
Capi. / Sales 2015 8,51x
Capitalization 516 M
More Financials
Latest news on IGI LABORIGI
10/23 IGI LABORATORIES : Announces Third Quarter 2014 Results
10/20 IGI LABORATORIES : To Hold Conference Call For 3rd Quarter 2014 Results
10/10 IGI LABORATORIES : To Hold Conference Call For 3rd Quarter 2014 Results
10/09 IGI LABORATORIES : Appoints Steven Koehler To Board Of Directors
10/01 IGI LABORATORIES : Acquires Two Products From Valeant Pharmaceuticals
09/25 IGI LABORATORIES : Acquires Eighteen Former Products From AstraZeneca
09/11 IGI LABORATORIES : Technical Roundup on Consumer Staples Equities -- Lorillard, ..
07/30 IGI LABORATORIES : Announces Second Quarter 2014 Results
07/24 IGI LABORATORIES : Announces Second Quarter 2014 Results
07/24 IGI LABORATORIES : Announces Change To Its Board Of Directors
07/18 IGI LABORATORIES : To Hold Conference Call For 2nd Quarter 2014 Results
07/09 IGI LABORATORIES : Added To The Russell 3000 Index
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF